Synthesis and evaluation of [18F]FBTA, a potential amyloid imaging agent

U. Berndt (Speaker), C. Stanetty, M. Berger, Herbert Kvaternik, Tanja Wolf, Claudia Kuntner, Thomas Wanek, Peter Angelberger, C. Noe

Research output: Chapter in Book or Conference ProceedingsConference Proceedings with Oral Presentationpeer-review

Abstract

ß-Amyloid(Aß)plaques and neurofibrillary tangles detected in post mortem brain are the defining characteristics of Alzheimer's disease (AD). In vitro imaging of Aß plaques could be very useful for early diagnosis and therapy monitoring of AD. A 11C-labelled benzothiazole-aniline, [11C]BTA, is the first Aß PET-tracer used in AD patients witz promising results (1).Here we report the radiosynthesis and evaluation of [18F]FBTA, a new [18F]analog of [11C]BTA.
Original languageEnglish
Title of host publicationJournal of Labelled Compounds and Radiopharmaceuticals
Pages86
Number of pages1
Publication statusPublished - 2007
EventThe 17th International Symposium on Radiopharmaceutical Sciences -
Duration: 1 Jan 2007 → …

Conference

ConferenceThe 17th International Symposium on Radiopharmaceutical Sciences
Period1/01/07 → …

Research Field

  • Biosensor Technologies

Keywords

  • [18F]FBTA
  • PET
  • Alzheimer's Disease
  • ß-Amyloid
  • [11C]BTA

Fingerprint

Dive into the research topics of 'Synthesis and evaluation of [18F]FBTA, a potential amyloid imaging agent'. Together they form a unique fingerprint.

Cite this